Site content: Global

Press Release

A robust method to study cancer heterogeneity in liquid biopsy

Copy Number Alteration Profiling of Single Circulating Tumor Cells which May Be used to Predict Response to Therapy   Scientists reported the development of a robust and...

Menarini-Silicon Biosystems and Swift Biosciences Announce Collaboration to Offer Customized NGS Technologies for Tumor Cell Analysis

Products Optimized for Targeted Resequencing and Exome Sequencing of FFPE Cells BOLOGNA, Italy, October 25, 2016 – Menarini-Silicon Biosystems Inc., a developer and manufacturer...